Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and growth factors regulate the aggressiveness and proliferative activity of keratocystic odontogenic tumors.

[1]  T. Kaczmarzyk,et al.  A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities. , 2012, International journal of oral and maxillofacial surgery.

[2]  F. Mannello,et al.  Nuclear localization of matrix metalloproteinases. , 2012, Progress in histochemistry and cytochemistry.

[3]  R. Jaeger,et al.  Invadopodia proteins, cortactin and membrane type I matrix metalloproteinase (MT1‐MMP) are expressed in ameloblastoma , 2011, Histopathology.

[4]  R. de Almeida Freitas,et al.  Immunohistochemical expression of matrix metalloproteinases 1, 2, 7, 9, and 26 in the calcifying cystic odontogenic tumor. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[5]  H. Galvão,et al.  Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  H. Galvão,et al.  Immunohistochemical expression of nuclear factor κB, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[7]  H. Zartab,et al.  Immunohistochemical Comparison of the Expression of p53 and MDM2 Proteins in Ameloblastomas and Keratocystic Odontogenic Tumors , 2011, The Journal of craniofacial surgery.

[8]  Sérgio de Melo Alves Júnior,et al.  Expression of metallothionein in ameloblastoma. A regulatory molecule? , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  Hyung Gyun Kim,et al.  Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling. , 2011, Molecular nutrition & food research.

[10]  J. Carvalho,et al.  A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[11]  Ingebrigt Sylte,et al.  Regulation of matrix metalloproteinase activity in health and disease , 2011, The FEBS journal.

[12]  P. Boffano,et al.  Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[13]  R. Leonardi,et al.  MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts. , 2010, Oral diseases.

[14]  P. Lequerica-Fernández,et al.  Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. , 2010, Medicina oral, patologia oral y cirugia bucal.

[15]  R. Jaeger,et al.  Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour , 2010, Histopathology.

[16]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[17]  I. van der Waal,et al.  Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. , 2010, Oral oncology.

[18]  J. Bodart.  Extracellular‐regulated kinase—mitogen‐activated protein kinase cascade: Unsolved issues , 2010, Journal of cellular biochemistry.

[19]  Brenda L. Nelson,et al.  Keratocystic Odontogenic Tumor , 2010, Head and neck pathology.

[20]  L. Campbell,et al.  Activated extracellular signal‐regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma , 2009, Cancer.

[21]  R. Buccione,et al.  Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix , 2009, Cancer and Metastasis Reviews.

[22]  Mohammad A. Ali.  Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[23]  K. Pereira,et al.  Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[24]  Alex Y Strongin,et al.  Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. , 2008, Cancer research.

[25]  D. Radisky,et al.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development , 2008, Clinical & Experimental Metastasis.

[26]  W. Parks,et al.  Activation and silencing of matrix metalloproteinases. , 2008, Seminars in cell & developmental biology.

[27]  A. Noël,et al.  Matrix metalloproteinases at cancer tumor-host interface. , 2008, Seminars in cell & developmental biology.

[28]  A. Ulhuq.  Cysts of the oral and maxillofacial regions , 2008, BDJ.

[29]  G. Ligresti,et al.  Extracellular Matrix: A Matter of Life and Death , 2008, Connective tissue research.

[30]  R. Herbst,et al.  Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice , 2007, Molecular Cancer Therapeutics.

[31]  S. Shukla,et al.  Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancer , 2007, Head & neck.

[32]  H. Galvão,et al.  Participação das metaloproteinases da matriz na etiopatogenia dos cistos odontogênicos , 2007 .

[33]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[34]  M. Ozsahin,et al.  The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications , 2006, Radiation oncology.

[35]  J. Delaissé,et al.  A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.

[36]  A. S. Moretti,et al.  Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity , 2004, Histopathology.

[37]  Y. Itoh,et al.  Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.

[38]  M. Shear.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. , 2002, Oral oncology.

[39]  M. Shear.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. , 2002, Oral oncology.

[40]  M. Shear,et al.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. , 2002, Oral oncology.

[41]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[42]  Y. Takenoshita,et al.  Interleukin-1α-dependent Regulation of Matrix Metalloproteinase-9 (MMP-9) Secretion and Activation in the Epithelial Cells of Odontogenic Jaw Cysts , 2000, Journal of dental research.

[43]  A. Piattelli,et al.  Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. , 1998, Oral oncology.

[44]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[45]  P. Toller,et al.  Origin and growth of cysts of the jaws. , 1967, Annals of the Royal College of Surgeons of England.

[46]  V. Olgac,et al.  Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts. , 2012, Turk patoloji dergisi.

[47]  I. Căruntu,et al.  Matrix metalloproteinases involvement in pathologic conditions. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[48]  I. van der Waal,et al.  Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview. , 2010, Oral oncology.

[49]  B. Fingleton.  Matrix metalloproteinases: roles in cancer and metastasis. , 2006, Frontiers in bioscience : a journal and virtual library.

[50]  H. Philipsen.  Keratocystic odontogenic tumour , 2005 .

[51]  Tang Hai-kuo.  Establishment and biological behavior of human ameloblastoma xenograft in nude mice , 2004 .

[52]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[53]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[54]  Growth Factors, Cytokines, Cell Cycle Molecules Matrix Metalloproteinase-9 and Cell Division in Neuroblastoma Cells and Bone Marrow Macrophages , 2022 .